Our findings suggest that this novel mechanism of CaMKII-mediated phosphorylation of RyR2 in pancreatic β cells contributes to the development of type 2 diabetes and may aid in the development of future therapeutic targets to regulate insulin secretion under pathological conditions. The gene discussed is INS; the disease is type 2 diabetes mellitus.